World News

EMA Recommends Granting a Marketing Authorisation for Camizestrant

Ogkologos - 5 Ιουνίου, 2026

New ESMO President 2029-2030 Elected

Ogkologos - 3 Ιουνίου, 2026

ESMO Calls for the Ring-Fenced Funding of Health Under the 2028-2034...

Ogkologos - 3 Ιουνίου, 2026

Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical...

Ogkologos - 3 Ιουνίου, 2026

FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax...

Ogkologos - 3 Ιουνίου, 2026

Adjuvant Selpercatinib Prolongs EFS Among Patients with Stage II or IIIA...

Ogkologos - 2 Ιουνίου, 2026

Zanidatamab Plus Chemotherapy Prolongs PFS Over Trastuzumab Plus Chemotherapy in Patients...

Ogkologos - 1 Ιουνίου, 2026

ESMO Highlights the Importance of a Strong EU Commitment Towards Robust...

Ogkologos - 29 Μαΐου, 2026

Metastatic Breast Cancer: ESMO Clinical Practice Guideline

Ogkologos - 29 Μαΐου, 2026

EMA Recommends Extending Indications for Decitabine / Cedazuridine

Ogkologos - 29 Μαΐου, 2026

1...151617...432 Σελίδα 16 από 432

MOST POPULAR

Strategy May Prevent Tumor Resistance to Targeted Cancer Therapies

17 Μαρτίου, 2023

FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic...

2 Σεπτεμβρίου, 2026

Woman with Nonverbal Autism Diagnosed with Breast Cancer After Caregiver Sister...

30 Οκτωβρίου, 2020

Adjuvant Dabrafenib Plus Trametinib Associated with Better RFS and DMFS than...

9 Ιουλίου, 2024

Φόρτωση περισσοτέρων

EMA Recommends Granting a Marketing Authorisation for Camizestrant

New ESMO President 2029-2030 Elected

ESMO Calls for the Ring-Fenced Funding of Health Under the 2028-2034...

Adding Apalutamide to Perioperative ADT Associated with Better Outcomes of Radical...

FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax...

Adjuvant Selpercatinib Prolongs EFS Among Patients with Stage II or IIIA...

Zanidatamab Plus Chemotherapy Prolongs PFS Over Trastuzumab Plus Chemotherapy in Patients...

ESMO Highlights the Importance of a Strong EU Commitment Towards Robust...

Metastatic Breast Cancer: ESMO Clinical Practice Guideline

EMA Recommends Extending Indications for Decitabine / Cedazuridine

MOST POPULAR

Strategy May Prevent Tumor Resistance to Targeted Cancer Therapies

FDA Grants Traditional Approval to Selpercatinib for Locally Advanced or Metastatic...

Woman with Nonverbal Autism Diagnosed with Breast Cancer After Caregiver Sister...

Adjuvant Dabrafenib Plus Trametinib Associated with Better RFS and DMFS than...

HOT NEWS

A Combination of Durvalumab-Tremelimumab with mFOLFOX6 Is Tolerable with Promising Activity...

Dr. Alan S. Rabson, Long-Time NCI Deputy Director and Cancer Research...

ESMO and ASCO publish joint consensus statement on streamlining clinical research

New on NCI’s Websites for June 2022

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ